Antisense approaches to immune modulation for transplant and autoimmune diseases

Current Opinion in Pharmacology

Volumn 5, Issue 5 SPEC.ISS., 2005, Pages 508-512

  Mourich, Dan V ^a   Marshall, Nikki B ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALICAFORSEN; ANTISENSE OLIGONUCLEOTIDE; BETA1A INTERFERON; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CYTOKINE; FINGOLIMOD; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; NATALIZUMAB; OLIGOMER; VERY LATE ACTIVATION ANTIGEN 4;

ALLERGIC ENCEPHALOMYELITIS; ANTIVIRAL ACTIVITY; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; BIOTECHNOLOGY; CLINICAL TRIAL; CROHN DISEASE; CYTOLOGY; DENDRITIC CELL; DIABETES MELLITUS; DRUG APPROVAL; DRUG EFFICACY; DRUG FATALITY; ENTERITIS; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION; GENE FUNCTION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOMODULATION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; MOLECULAR BIOLOGY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REPERFUSION INJURY; REVIEW; T LYMPHOCYTE; ULCERATIVE COLITIS;

EID: 24344463460     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2005.04.018     Document Type: Review

References (24)

1. S.T. Crooke Progress in antisense technology Annu Rev Med 55 2004 61-95
2. J. Kurreck Antisense technologies. Improvement through novel chemical modifications Eur J Biochem 270 2003 1628-1644
3. K. Praditpornsilpa Y. Avihingsanon New concepts in organ transplantation Transplant Proc 36 2004 1228-1231
4. G. Van Assche P. Rutgeerts Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol 288 2005 G169-G174
5. K.J. Myers D.R. Witchell M.J. Graham S. Koo M. Butler T.P. Condon Antisense oligonucleotide blockade of alpha 4 integrin prevents and reverses clinical symptoms in murine experimental autoimmune encephalomyelitis J Neuroimmunol 160 2005 12-24
6. B.R. Yacyshyn W.Y. Chey J. Goff B. Salzberg R. Baerg A.L. Buchman J. Tami R. Yu E. Gibiansky W.R. Shanahan Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease Gut 51 2002 30-36
7. S.J. van Deventer J.A. Tami M.K. Wedel A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis Gut 53 2004 1646-1651
8. L.V. Kiew A.S. Munavvar C.H. Law A.N. Azizan A.R. Nazarina K. Sidik E.J. Johns Effect of antisense oligodeoxynucleotides for ICAM-1 on renal ischaemia-reperfusion injury in the anaesthetised rat J Physiol 557 2004 981-989
9. A.M. Ortiz P. Troncoso B.D. Kahan Prevention of renal ischemic reperfusion injury using FTY 720 and ICAM-1 antisense oligonucleotides Transplant Proc 35 2003 1571-1574
10. W. Chen R.M. Langer S. Janczewska L. Furian R. Geary X. Qu M. Wang R. Verani T. Condon K. Stecker et al. Methoxyethyl-modified intercellular adhesion molecule-1 antisense phosphorothiateoligonucleotides inhibit allograft rejection, ischemic-reperfusion injury, and cyclosporine-induced nephrotoxicity Transplantation 79 2005 401-408
11. C. Sheridan Third Tysabri adverse case hits drug class Nat Rev Drug Discov 4 2005 357-358
12. K.J. Myers S. Murthy A. Flanigan D.R. Witchell M. Butler S. Murray A. Siwkowski D. Goodfellow K. Madsen B. Baker Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis J Pharmacol Exp Ther 304 2003 411-424
13. T. Sakamoto E. Miyazaki Y. Aramaki H. Arima M. Takahashi Y. Kato M. Koga S. Tsuchiya Improvement of dermatitis by iontophoretically delivered antisense oligonucleotides for interleukin-10 in NC/Nga mice Gene Ther 11 2004 317-324
14. M. Jiankuo W. Xingbing H. Baojun W. Xiongwin L. Zhuoya X. Ping X. Yong L. Anting H. Chunsong G. Feili T. Jinquan Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft J Immunol 170 2003 1556-1565
15. R.M. Steinman D. Hawiger M.C. Nussenzweig Tolerogenic dendritic cells Annu Rev Immunol 21 2003 685-711
16. S.A. Quezada L.Z. Jarvinen E.F. Lind R.J. Noelle CD40/CD154 interactions at the interface of tolerance and immunity Annu Rev Immunol 22 2004 307-328
17. B.M. Carreno M. Collins The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses Annu Rev Immunol 20 2002 29-53
18. H. von Boehmer Mechanisms of suppression by suppressor T cells Nat Immunol 6 2005 338-344
19. X. Liang L. Lu Z. Chen T. Vickers H. Zhang J.J. Fung S. Qian Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival Transplantation 76 2003 721-729
20. J. Machen J. Harnaha R. Lakomy A. Styche M. Trucco N. Giannoukakis Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells J Immunol 173 2004 4331-4341
21. D. Gao A.H. Wagner S. Fankhaenel T. Stojanovic S. Schweyer S. Panzner M. Hecker CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis Gut 54 2005 70-77
22. A.E. Lovett-Racke A.E. Rocchini J. Choy S.C. Northrop R.Z. Hussain R.B. Ratts D. Sikder M.K. Racke Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes Immunity 21 2004 719-731
23. M. Mayne T. Moffatt H. Kong P.J. McLaren K.R. Fowke K.G. Becker M. Namaka A. Schenck B. Bardoni C.N. Bernstein M. Melanson CYFIP2 is highly abundant in CD4+ cells from multiple sclerosis patients and is involved in T cell adhesion Eur J Immunol 34 2004 1217-1227
24. M.A. Ansari M. Dhar V. Muthukrishnan T.L. Morton N. Bakht J.D. Jacobson Administration of antisense oligonucleotides to Galpha(Q/11) reduces the severity of murine lupus Biochimie 85 2003 627-632